In recent years, both cytokines and BDNF have been proposed as potential biomarkers of cognitive impairment in a range of clinical populations [40], including individuals with Alzheimer’s disease [41], Parkinson’s disease [42] and the elderly [43]. Here, BDNF is linked to early-onset autosomal dominant Alzheimer disease.